159 related articles for article (PubMed ID: 26967388)
1. Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma.
Unruh D; Ünlü B; Lewis CS; Qi X; Chu Z; Sturm R; Keil R; Ahmad SA; Sovershaev T; Adam M; Van Dreden P; Woodhams BJ; Ramchandani D; Weber GF; Rak JW; Wolberg AS; Mackman N; Versteeg HH; Bogdanov VY
Oncotarget; 2016 May; 7(18):25264-75. PubMed ID: 26967388
[TBL] [Abstract][Full Text] [Related]
2. Alternatively spliced tissue factor contributes to tumor spread and activation of coagulation in pancreatic ductal adenocarcinoma.
Unruh D; Turner K; Srinivasan R; Kocatürk B; Qi X; Chu Z; Aronow BJ; Plas DR; Gallo CA; Kalthoff H; Kirchhofer D; Ruf W; Ahmad SA; Lucas FV; Versteeg HH; Bogdanov VY
Int J Cancer; 2014 Jan; 134(1):9-20. PubMed ID: 23754313
[TBL] [Abstract][Full Text] [Related]
3. Activation of carbonic anhydrase IX by alternatively spliced tissue factor under late-stage tumor conditions.
Ramchandani D; Unruh D; Lewis CS; Bogdanov VY; Weber GF
Lab Invest; 2016 Dec; 96(12):1234-1245. PubMed ID: 27721473
[TBL] [Abstract][Full Text] [Related]
4. Levels of Alternatively Spliced Tissue Factor in the Plasma of Patients with Pancreatic Cancer May Help Predict Aggressive Tumor Phenotype.
Unruh D; Sagin F; Adam M; Van Dreden P; Woodhams BJ; Hart K; Lindsell CJ; Ahmad SA; Bogdanov VY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1206-11. PubMed ID: 25963480
[TBL] [Abstract][Full Text] [Related]
5. Role of alternatively spliced tissue factor in pancreatic cancer growth and angiogenesis.
Signaevsky M; Hobbs J; Doll J; Liu N; Soff GA
Semin Thromb Hemost; 2008 Mar; 34(2):161-9. PubMed ID: 18645921
[TBL] [Abstract][Full Text] [Related]
6. SOX2 functions as a molecular rheostat to control the growth, tumorigenicity and drug responses of pancreatic ductal adenocarcinoma cells.
Wuebben EL; Wilder PJ; Cox JL; Grunkemeyer JA; Caffrey T; Hollingsworth MA; Rizzino A
Oncotarget; 2016 Jun; 7(23):34890-906. PubMed ID: 27145457
[TBL] [Abstract][Full Text] [Related]
7. A First-In-Class, Humanized Antibody Targeting Alternatively Spliced Tissue Factor: Preclinical Evaluation in an Orthotopic Model of Pancreatic Ductal Adenocarcinoma.
Lewis CS; Karve A; Matiash K; Stone T; Li J; Wang JK; Versteeg HH; Aronow BJ; Ahmad SA; Desai PB; Bogdanov VY
Front Oncol; 2021; 11():691685. PubMed ID: 34395257
[TBL] [Abstract][Full Text] [Related]
8. hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma.
Lastraioli E; Perrone G; Sette A; Fiore A; Crociani O; Manoli S; D'Amico M; Masselli M; Iorio J; Callea M; Borzomati D; Nappo G; Bartolozzi F; Santini D; Bencini L; Farsi M; Boni L; Di Costanzo F; Schwab A; Onetti Muda A; Coppola R; Arcangeli A
Br J Cancer; 2015 Mar; 112(6):1076-87. PubMed ID: 25719829
[TBL] [Abstract][Full Text] [Related]
9. Alternatively spliced tissue factor promotes breast cancer growth in a β1 integrin-dependent manner.
Kocatürk B; Van den Berg YW; Tieken C; Mieog JS; de Kruijf EM; Engels CC; van der Ent MA; Kuppen PJ; Van de Velde CJ; Ruf W; Reitsma PH; Osanto S; Liefers GJ; Bogdanov VY; Versteeg HH
Proc Natl Acad Sci U S A; 2013 Jul; 110(28):11517-22. PubMed ID: 23801760
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
12. Alternatively spliced tissue factor synergizes with the estrogen receptor pathway in promoting breast cancer progression.
Kocatürk B; Tieken C; Vreeken D; Ünlü B; Engels CC; de Kruijf EM; Kuppen PJ; Reitsma PH; Bogdanov VY; Versteeg HH
J Thromb Haemost; 2015 Sep; 13(9):1683-93. PubMed ID: 26179105
[TBL] [Abstract][Full Text] [Related]
13. Stem cell marker nestin is critical for TGF-β1-mediated tumor progression in pancreatic cancer.
Su HT; Weng CC; Hsiao PJ; Chen LH; Kuo TL; Chen YW; Kuo KK; Cheng KH
Mol Cancer Res; 2013 Jul; 11(7):768-79. PubMed ID: 23552743
[TBL] [Abstract][Full Text] [Related]
14. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
[TBL] [Abstract][Full Text] [Related]
15. Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma.
Kothari A; Flick MJ
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066284
[TBL] [Abstract][Full Text] [Related]
16. BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration.
Dufrusine B; Damiani V; Capone E; Pieragostino D; Dainese E; De Marco M; Reppucci F; Turco MC; Rosati A; Marzullo L; Sala G; Sallese M; De Laurenzi V
J Cell Biochem; 2022 Jan; 123(1):65-76. PubMed ID: 34741485
[TBL] [Abstract][Full Text] [Related]
17. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
[TBL] [Abstract][Full Text] [Related]
19. A gene expression signature of epithelial tubulogenesis and a role for ASPM in pancreatic tumor progression.
Wang WY; Hsu CC; Wang TY; Li CR; Hou YC; Chu JM; Lee CT; Liu MS; Su JJ; Jian KY; Huang SS; Jiang SS; Shan YS; Lin PW; Shen YY; Lee MT; Chan TS; Chang CC; Chen CH; Chang IS; Lee YL; Chen LT; Tsai KK
Gastroenterology; 2013 Nov; 145(5):1110-20. PubMed ID: 23896173
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
Geismann C; Morscheck M; Koch D; Bergmann F; Ungefroren H; Arlt A; Tsao MS; Bachem MG; Altevogt P; Sipos B; Fölsch UR; Schäfer H; Müerköster SS
Cancer Res; 2009 May; 69(10):4517-26. PubMed ID: 19435915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
